Customize your JAMA Network experience by selecting one or more topics from the list below.
Updated Funding Information: In the Original Contribution entitled “Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in Infants: A Randomized Controlled Trial,” published in the January 9/16, 2008, issue of JAMA (2008;299:173-184), the Funding/Support paragraph should have included the following: The Oxford Vaccine Group receives funding from the NIHR Oxford Partnership Comprehensive Biomedical Research Centre program (including salary support for Ms John and Dr Snape). This article has been corrected online.
Updated Funding Information in: Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in Infants: A Randomized Controlled Trial. JAMA. 2011;305(11):1096. doi:10.1001/jama.2011.306
Coronavirus Resource Center
Create a personal account or sign in to: